Cardiogenic Shock Predicts Long-term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention
Autor: | Arnoud W van 't Hof, Jan Henk Dambrink, Jan Paul Ottervanger, Marcel Gosselink, Veemal Hemradj, Elvin Kedhi, Harry Suryapranata |
---|---|
Rok vydání: | 2016 |
Předmět: |
Male
medicine.medical_specialty Acute coronary syndrome Time Factors medicine.medical_treatment Vascular damage Radboud Institute for Health Sciences [Radboudumc 16] Shock Cardiogenic Clinical Investigations Kaplan-Meier Estimate 030204 cardiovascular system & hematology Risk Assessment 03 medical and health sciences 0302 clinical medicine Percutaneous Coronary Intervention Risk Factors Internal medicine Angioplasty medicine Humans 030212 general & internal medicine Myocardial infarction Hospital Mortality Prospective Studies Survivors Prospective cohort study Aged Netherlands Proportional Hazards Models business.industry Cardiogenic shock Hazard ratio Percutaneous coronary intervention General Medicine Middle Aged medicine.disease Treatment Outcome Cohort Multivariate Analysis Cardiology ST Elevation Myocardial Infarction Female Cardiology and Cardiovascular Medicine business |
Zdroj: | Clinical Cardiology, 39, 11, pp. 665-669 Clinical Cardiology, 39, 665-669 |
ISSN: | 1932-8737 0160-9289 |
Popis: | Contains fulltext : 172076.pdf (Publisher’s version ) (Open Access) BACKGROUND: ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock (CS) has a poor prognosis. Recently published data suggested, however, that CS does not affect long-term mortality in hospital survivors of STEMI. We investigated whether this could be confirmed in a larger cohort. HYPOTHESIS: STEMI complicated by CS leads to worse long-term survival. METHODS: A prospective cohort study was performed in 7412 consecutive patients with STEMI treated by primary percutaneous coronary intervention (angioplasty). The predictive value of CS on long-term mortality was assessed in hospital survivors. Multivariate analysis, adjusting for differences in baseline variables, was performed to assess the independent prognostic value of CS. RESULTS: Cardiogenic shock was observed in 387 patients (5.2%). The total in-hospital mortality was 254 (3.4%), and mortality was significantly higher in patients with CS (20.0% vs 2.6%; P < 0.001). The 1-year mortality in hospital survivors was 10.3% in patients with CS and 3.9% in patients without CS (P < 0.001). After multivariate analysis, CS was still a significant predictor of long-term mortality in hospital survivors (hazard ratio: 2.6, 95% confidence interval: 1.64-4.01). CONCLUSIONS: Cardiogenic shock remains a strong predictor of long-term mortality in hospital survivors of STEMI treated by primary percutaneous coronary intervention. |
Databáze: | OpenAIRE |
Externí odkaz: |